Search Course Outline
Showing 25 course outlines from 2713 matches
776
MEDSCI 318
: Pharmacokinetics and Drug Toxicity2024 Semester One (1243)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
Restriction: MEDSCI 303, 306, 321
777
MEDSCI 318
: Pharmacokinetics and Drug Toxicity2023 Semester One (1233)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
Restriction: MEDSCI 303, 306, 321
778
MEDSCI 318
: Pharmacokinetics and Drug Toxicity2022 Semester One (1223)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
Restriction: MEDSCI 303, 306, 321
779
MEDSCI 318
: Pharmacokinetics and Drug Toxicity2021 Semester One (1213)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
Restriction: MEDSCI 303, 306, 321
780
MEDSCI 319
: Molecular Pharmacology2025 Semester One (1253)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
Restriction: MEDSCI 304, 321
781
MEDSCI 319
: Molecular Pharmacology2024 Semester One (1243)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
Restriction: MEDSCI 304, 321
782
MEDSCI 319
: Molecular Pharmacology2023 Semester One (1233)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
Restriction: MEDSCI 304, 321
783
MEDSCI 319
: Molecular Pharmacology2022 Semester One (1223)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
Restriction: MEDSCI 304, 321
784
MEDSCI 319
: Molecular Pharmacology2021 Semester One (1213)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
Restriction: MEDSCI 304, 321
785
MEDSCI 320
: Pharmacology of the Brain and Body2025 Semester Two (1255)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
Restriction: MEDSCI 305, 307
786
MEDSCI 320
: Pharmacology of the Brain and Body2024 Semester Two (1245)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
Restriction: MEDSCI 305, 307
787
MEDSCI 320
: Pharmacology of the Brain and Body2023 Semester Two (1235)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
Restriction: MEDSCI 305, 307
788
MEDSCI 320
: Pharmacology of the Brain and Body2022 Semester Two (1225)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
Restriction: MEDSCI 305, 307
789
MEDSCI 320
: Pharmacology of the Brain and Body2021 Semester Two (1215)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
Restriction: MEDSCI 305, 307
790
MEDSCI 321
: Special Topic: Concepts in Pharmacology2022 Semester One (1223)
Explores the cellular and molecular mechanisms of drug action plus drug discovery and development from the perspective of in silico modelling, biochemical assessment, intracellular signalling and human disease. Considers the pharmacokinetic processes of input, distribution and elimination involved in achieving clinically-relevant drug concentrations. Describes the link between concentration and effect and the time course of effect. Explores factors such as disease progression, drug metabolism, drug-drug interactions, pharmacogenetics, use in selected populations and in various pathological conditions that may influence both clinical effectiveness and drug toxicity.
Prerequisite: MEDSCI 204 and 30 points from BIOSCI 203, MEDSCI 203, 205
Restriction: MEDSCI 303, 306, 318, 319, 735
Restriction: MEDSCI 303, 306, 318, 319, 735
791
MEDSCI 700
: Drug Discovery Biology2025 Semester One (1253)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
No pre-requisites or restrictions
792
MEDSCI 700
: Drug Discovery Biology2024 Semester One (1243)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
No pre-requisites or restrictions
793
MEDSCI 700
: Drug Discovery Biology2023 Semester One (1233)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
No pre-requisites or restrictions
794
MEDSCI 700
: Drug Discovery Biology2021 Semester One (1213)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
No pre-requisites or restrictions
795
MEDSCI 700
: Drug Discovery Biology2020 Semester Two (1205)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
No pre-requisites or restrictions
796
MEDSCI 701
: Special Studies in Medical Science2024 Semester Two (1245)
The critical review and analysis of research literature relating to a research topic. Components include an extensive literature review article defining the current knowledge relevant to a particular research area, a research proposal outlining proposed Masters research topic and its significance, and a formal presentation of the proposal. Suitable for students intending to undertake a Masters thesis.
Restriction: MEDSCI 702, 744
797
MEDSCI 701
: Special Studies in Medical Science2024 Semester One (1243)
The critical review and analysis of research literature relating to a research topic. Components include an extensive literature review article defining the current knowledge relevant to a particular research area, a research proposal outlining proposed Masters research topic and its significance, and a formal presentation of the proposal. Suitable for students intending to undertake a Masters thesis.
Restriction: MEDSCI 702, 744
798
MEDSCI 701
: Special Studies in Medical Science2023 Semester Two (1235)
The critical review and analysis of research literature relating to a research topic. Components include an extensive literature review article defining the current knowledge relevant to a particular research area, a research proposal outlining proposed Masters research topic and its significance, and a formal presentation of the proposal. Suitable for students intending to undertake a Masters thesis.
Restriction: MEDSCI 702, 744
799
MEDSCI 701
: Special Studies in Medical Science2023 Semester One (1233)
The critical review and analysis of research literature relating to a research topic. Components include an extensive literature review article defining the current knowledge relevant to a particular research area, a research proposal outlining proposed Masters research topic and its significance, and a formal presentation of the proposal. Suitable for students intending to undertake a Masters thesis.
Restriction: MEDSCI 702, 744
800
MEDSCI 701
: Special Studies in Medical Science2022 Semester Two (1225)
The critical review and analysis of research literature relating to a research topic. Components include an extensive literature review article defining the current knowledge relevant to a particular research area, a research proposal outlining proposed Masters research topic and its significance, and a formal presentation of the proposal. Suitable for students intending to undertake a Masters thesis.
Restriction: MEDSCI 702, 744
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109